The Supreme Court's decision in Wyeth v. Levine recognizes that the FDA's approval of a drug label does not pre-empt state law failure-to-warn claims.
The Issue with Phenergan
Rarely has a defendant in a drug case been able to compile such a favorable set of facts to present to the Court. Phenergan, marketed since the 1950s, is an anti-nausea prescription medication.
This premium content is locked for LawJournalNewsletters subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN LawJournalNewsletters
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already have an account? Sign In Now
For enterprise-wide or corporate access, please contact Customer Service at [email protected] or call 1-877-256-2473.